Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FertyBiotic Hombre
- Development stage
- Unknown
- Lead developer
- Fertypharm
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
FertyBiotic Hombre (FertyBiotic Man) is a probiotic-based dietary supplement developed by Fertypharm, a Spanish company dedicated to fertility health. It is positioned as the first food supplement to integrate specific probiotics with traditional nutritional components to support male reproductive health. The formulation includes docosahexaenoic acid (DHA), coenzyme Q10, zinc, and selenium, alongside probiotic strains *Lacticaseibacillus rhamnosus* and *Lactobacillus crispatus*. The supplement operates through a dual mechanism of microbiota modulation and antioxidant nutritional support. Zinc and selenium contribute to normal fertility, reproduction, and spermatogenesis, while the probiotics help improve sperm parameters such as concentration, motility, and DNA fragmentation by reducing oxidative stress and balancing the male reproductive tract microbiota.
- Brand names
- FertyBiotic HombreFertyBiotic Man
- Other names
- FertyBiotic Hombre (FertyBiotic Man)
Beyond the preview
Go deeper on FertyBiotic Hombre.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FertyBiotic Hombre.